UFP Technologies, Inc.
UFPT Healthcare Medical Devices
UFP Technologies, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $602.8 million, up 19.5% from fiscal 2024.
- Revenue
- +11.6%
- EPS
- +25.6%
- Free cash flow
- −35.8%
- Total debt
- −40.2%
Quarter to September 2026, against a year earlier
Follow UFPT
Alert me
UFP Technologies, Inc. (UFPT) EV/FCF
As of 5 November 2026, UFP Technologies, Inc. (UFPT) trades at a EV/FCF of 38.7×. Over the past ten years it has ranged from −140× (September 2016) to 445× (June 2022); the current reading is higher than 71% of that period.
EV/FCF, daily
Embed this chart
Annual newest first
| Period | EV/FCF | Change |
|---|---|---|
| FY2025 | 23.3× | (39.36%) |
| FY2024 | 38.4× | (8.29%) |
| FY2023 | 41.9× | (51.65%) |
| FY2022 | 86.6× | 30.13% |
| FY2021 | 66.5× | 324.34% |
| FY2020 | 15.7× | 8.57% |
| FY2019 | 14.4× | (4.93%) |
| FY2018 | 15.2× | (33.42%) |
| FY2017 | 22.8× | (68.82%) |
| FY2016 | 73.2× | — |
Quarterly newest first
| Period | EV/FCF | Change |
|---|---|---|
| Sep 2026 | 38.6× | 9.19% |
| Jun 2026 | 35.4× | 51.26% |
| Mar 2026 | 23.4× | 0.41% |
| Dec 2025 | 23.3× | 21.10% |
| 43 more quarters | Free account |
Against its own ten years
EV/FCF against peers
| Company | EV/FCF |
|---|---|
| BFLY Butterfly Network, Inc. compare | −56.1× |
| NVCR NovoCure Limited compare | −52.9× |
| ESTA Establishment Labs Holdings Inc. compare | −51.7× |
| ALMR Alamar Biosciences, Inc. compare | −14.9× |
| INSP Inspire Medical Systems, Inc. compare | 16.4× |
| UFPT UFP Technologies, Inc. | 38.7× |
| TMDX TransMedics Group, Inc. compare | 62.5× |
| NEOG Neogen Corporation compare | 63.4× |
| AXGN AxoGen, Inc. compare | 118× |
What EV/FCF is
EV/Free CF shows how the value of a whole company, debt included, compares with the free cash its business produces.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ (Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM))
More on UFPT
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement